Loading...
Therapeutic Application of Drug-Conjugated HER2 Oligobody (HER2-DOligobody)
Antibody drug conjugates (ADCs), consisting of a cancer-specific antibody and cytotoxic payload, are shown to be a potent class of anticancer therapeutics, with enhanced therapeutic efficacy and reduced “off-target” side effects. However, the therapeutic window of ADCs is narrowed by problems such a...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7246698/ https://ncbi.nlm.nih.gov/pubmed/32384770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093286 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|